Edinburgh Research Explorer

Prof John Smyth

(Former employee or visitor)

  1. 2012
  2. Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy

    Storey, D. J., McLaren, D. B., Atkinson, M. A., Butcher, I., Frew, L. C., Smyth, J. F. & Sharpe, M., Jun 2012, In : Annals of oncology. 23, 6, p. 1542-+ 8 p.

    Research output: Contribution to journalArticle

  3. Clinically relevant fatigue in recurrence-free prostate cancer survivors

    Storey, D. J., McLaren, D. B., Atkinson, M. A., Butcher, I., Liggatt, S., O'Dea, R., Smyth, J. F. & Sharpe, M., Jan 2012, In : Annals of oncology. 23, 1, p. 65-72 8 p.

    Research output: Contribution to journalArticle

  4. Association of galectin-3 expression with melanoma progression and prognosis

    Brown, E. R., Doig, T., Anderson, N., Brenn, T., Doherty, V., Xu, Y., Bartlett, J. M. S., Smyth, J. F. & Melton, D. W., 2012, In : European Journal of Cancer. 48, 6, p. 865-74 10 p.

    Research output: Contribution to journalArticle

  5. 2011
  6. Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy

    Storey, D. J., McLaren, D. B., Atkinson, M. A., Butcher, I., Frew, L. C., Smyth, J. F. & Sharpe, M., 1 Nov 2011, In : International Braz J Urol. 37, 6, p. 798 1 p.

    Research output: Contribution to journalArticle

  7. The interface between medical oncology and supportive and palliative cancer care

    Storey, D. J., Fallon, M. T. & Smyth, J. F., 2011, In : Seminars in oncology. 38, 3, p. 337-42 6 p.

    Research output: Contribution to journalArticle

  8. 2010
  9. Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancer

    Faluyi, O. O., Gourley, C., Smyth, J. F., Faratian, D., Williams, A. R., Rye, T., Rye, R., Stewart, M. & Mackean, M. J., Dec 2010, In : International Journal of Gynecological Cancer. 20, 9, p. 1511-7 7 p.

    Research output: Contribution to journalArticle

  10. Investigator-initiated trials of targeted oncology agents: why independent research is at risk?

    Bergmann, L., Berns, B., Dalgleish, A. G., von Euler, M., Hecht, T. T., Lappin, G. L., Reed, N., Palmeri, S., Smyth, J., Embacher-Aichorn, S., Zwierzina, H. & Biotherapy Dev Assoc, Aug 2010, In : Annals of oncology. 21, 8, p. 1573-1578 6 p.

    Research output: Contribution to journalLiterature review

  11. Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine

    Dangoor, A., Lorigan, P., Keilholz, U., Schadendorf, D., Harris, A., Ottensmeier, C., Smyth, J., Hoffmann, K., Anderson, R., Cripps, M., Schneider, J. & Hawkins, R., Jun 2010, In : Cancer Immunology, Immunotherapy. 59, 6, p. 863-873 11 p.

    Research output: Contribution to journalArticle

  12. WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis

    Paige, A. J. W., Zucknick, M., Janczar, S., Paul, J., Mein, C. A., Taylor, K. J., Stewart, M., Gourley, C., Richardson, S., Perren, T., Ganesan, T. S., Smyth, J. F., Brown, R. & Gabra, H., Mar 2010, In : European Journal of Cancer. 46, 4, p. 818-825 8 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 Next